AstraZeneca said on Friday it has agreed to a research deal with Chinese drugmaker CSPC Pharmaceuticals worth up to $5.22 billion to focus on AI-enabled initiatives.
(Reporting by Pushkala Aripaka in Bengaluru)
The European Central Bank secured key parliamentary backing on Tuesday for the launch of a digital euro, an electronic means...
London's domestically focussed FTSE index slipped to a one-week low on Monday, bogged down by political uncertainty after Prime Minister...
Sterling slipped and UK borrowing costs edged up on Monday, after Prime Minister Keir Starmer said he would resign and...
Global demand for electric vehicles rose for a third straight month in May, as subsidies and high petrol prices continued...
A framework agreement between the U.S. and Iran on terms to end their war and reopen the Strait of Hormuz...
Sweden's Securitas, one of the world's largest security services providers, on Monday set new long-term financial targets as part of...
© 2024 SEMG.
